Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1983-02-18
1984-11-20
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
424200, 424258, 424274, 2601125K, A61K 3700, A01N 5700, A01N 4342, A01N 4336, C07C10352
Patent
active
044838506
ABSTRACT:
N-Terminal substituted oligopeptides are disclosed. The compounds are angiotensin converting enzyme inhibitors useful as antihypertensives.
REFERENCES:
patent: 4052511 (1977-10-01), Cushman et al.
patent: 4129571 (1978-12-01), Ondetti et al.
patent: 4154960 (1979-05-01), Ondetti et al.
patent: 4303583 (1981-12-01), Kim et al.
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4350704 (1982-09-01), Hoefle et al.
patent: 4385180 (1983-05-01), Kim et al.
D. W. Cushman, et al., Biochemistry, 16, 5484, (1977).
Y. Piquilloud, et al., Biochem. Biophys. Acta, 206, 136 (1970).
Weeks, et al., Proc. Soc. Exp. Biol. Med., 104, 636, (1969).
Koletsky, et al., Proc. Soc. Exp. Biol. Med., 125, 96, (1967).
Patchett Arthur A.
Ruyle William V.
Merck & Co. , Inc.
Mitri Salvatore C.
Monaco Mario A.
Phillips Delbert R.
LandOfFree
N-Terminal substituted oligopeptide converting enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Terminal substituted oligopeptide converting enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Terminal substituted oligopeptide converting enzyme inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189014